Clinical Trial Update: AMT-116 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This document describes an ongoing Phase 1 clinical trial of AMT-116 in patients with advanced solid tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• AMT-116

Snippet

Sponsor: Multitude Therapeutics Inc. | Conditions: Advanced Solid Tumor | Phase 1 | Status: RECRUITING